Gene therapy - Wikipedia
In the medicine field, gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. The first attempt at modifying human DNA was performed in 1980 by Martin Cline, but the first successful nuclear gene transfer in humans, approved by the National Institutes of Health, was performed in May 1989.
Gene therapy | Define Gene therapy at Dictionary.com
Gene therapy definition, the application of genetic engineering to the transplantation of genes into human cells in order to cure a disease caused by a genetic defect, as a missing enzyme. See more.
The Forever Fix: Gene Therapy and the Boy Who Saved It ...
Fascinating narrative science that explores the next frontier in medicine and genetics through the very personal prism of the children and families gene therapy has touched.
Gene Therapy Net - News, Conferences, Vectors, Literature ...
Gene Therapy Net is the web resource for patients and professionals interested in gene therapy.The objectives of Gene Therapy Net are to be the information resource for basic and clinical research in gene therapy, cell therapy, and genetic vaccines, and to serve as a network in the exchange of information and news related to above areas.
Tay-Sachs Gene Therapy Consortium
The Tay-Sachs Gene Therapy Consortium was founded in 2007 to develop a safe and effective gene-based treatment for the closely related Tay-Sachs and Sandhoff diseases (subtypes of GM2 gangliosidosis).
FDA approval brings first gene therapy to the United States
Español. The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer ...
GeoGene: Gene Therapy, What it is, The process and Vectors ...
Gene Therapy What is Gene Therapy? Certain diseases are caused by faulty genes which produce defective proteins.The symptoms of genetic disease are the result of subsequent disrupted vital cell processes caused by missing or defective proteins.
AveXis: A Clinical-Stage Gene Therapy Company
AveXis, now a Novartis Company, is a clinical-stage gene therapy company relentlessly focused on bringing gene therapy out of the lab and into the clinical setting for patients and families devastated by rare and life-threatening neurological genetic diseases.
F.D.A. Approves First Gene-Altering Leukemia Treatment ...
The Food and Drug Administration approved the first treatment that genetically alters a patient’s own cells to fight cancer. It will cost $475,000.
Cellular & Gene Therapy Guidances
This page contains a listing of cellular and gene therapy guidances.